Abstract
In this study, we examined the prevalence of and mechanisms of decreased susceptibility to either imipenem or meropenem in Klebsiella pneumoniae isolates. A total of 230 clinical isolates of K. pneumoniae were collected from 13 clinical laboratories from a nationwide distribution. The MICs of imipenem and meropenem were determined by the agar dilution method. To characterize the isolates with decreased susceptibility to carbapenems (MICs of >2 μg/mL), we performed polymerase chain reaction amplification of a variety of β-lactamase genes, isoelectric focusing, and outer membrane profile analysis using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry. Three isolates (BD6, BD8, and KN16) exhibited decreased susceptibility to carbapenems with imipenem MICs of 1, 4, and 8 μg/mL and meropenem MICs of 4, 8, and 4, respectively. Isolate BD6 produced bla TEM-1 , bla SHV-12 , and bla OXA-17 ; isolate BD8 produced bla GES-3 , bla SHV-12 , and bla OXA-17 ; and isolate KN16 produced bla TEM-11 , bla SHV-12 , and bla DHA-1 . In all the 3 isolates, OmpK35 porin was not expressed, and in 1 isolate (KN16), OmpK36 was not expressed either. The prevalence of decreased susceptibility to carbapenems was low (1.3%), and none of them showed overt resistance to carbapenems. Decreased susceptibility to carbapenems can occur in K. pneumoniae when bla GES-3 , bla TEM-11 , bla SHV-12 , bla OXA-17 , and/or bla DHA-1 are produced in combination with porin loss. In addition, to our knowledge, this is the 1st report of bla OXA-17 in Enterobacteriaceae.
| Original language | English |
|---|---|
| Pages (from-to) | 85-91 |
| Number of pages | 7 |
| Journal | Diagnostic Microbiology and Infectious Disease |
| Volume | 57 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2007 Jan 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Infectious Diseases
Cite this
}
Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates. / Kim, Soo Young; Park, Yeon Joon; Yu, Jin Kyung; Kim, Han Sik; Park, Yong Sung; Yoon, Jong-Bok; Yoo, Jin Young; Lee, Kyungwon.
In: Diagnostic Microbiology and Infectious Disease, Vol. 57, No. 1, 01.01.2007, p. 85-91.Research output: Contribution to journal › Article
TY - JOUR
T1 - Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates
AU - Kim, Soo Young
AU - Park, Yeon Joon
AU - Yu, Jin Kyung
AU - Kim, Han Sik
AU - Park, Yong Sung
AU - Yoon, Jong-Bok
AU - Yoo, Jin Young
AU - Lee, Kyungwon
PY - 2007/1/1
Y1 - 2007/1/1
N2 - In this study, we examined the prevalence of and mechanisms of decreased susceptibility to either imipenem or meropenem in Klebsiella pneumoniae isolates. A total of 230 clinical isolates of K. pneumoniae were collected from 13 clinical laboratories from a nationwide distribution. The MICs of imipenem and meropenem were determined by the agar dilution method. To characterize the isolates with decreased susceptibility to carbapenems (MICs of >2 μg/mL), we performed polymerase chain reaction amplification of a variety of β-lactamase genes, isoelectric focusing, and outer membrane profile analysis using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry. Three isolates (BD6, BD8, and KN16) exhibited decreased susceptibility to carbapenems with imipenem MICs of 1, 4, and 8 μg/mL and meropenem MICs of 4, 8, and 4, respectively. Isolate BD6 produced bla TEM-1 , bla SHV-12 , and bla OXA-17 ; isolate BD8 produced bla GES-3 , bla SHV-12 , and bla OXA-17 ; and isolate KN16 produced bla TEM-11 , bla SHV-12 , and bla DHA-1 . In all the 3 isolates, OmpK35 porin was not expressed, and in 1 isolate (KN16), OmpK36 was not expressed either. The prevalence of decreased susceptibility to carbapenems was low (1.3%), and none of them showed overt resistance to carbapenems. Decreased susceptibility to carbapenems can occur in K. pneumoniae when bla GES-3 , bla TEM-11 , bla SHV-12 , bla OXA-17 , and/or bla DHA-1 are produced in combination with porin loss. In addition, to our knowledge, this is the 1st report of bla OXA-17 in Enterobacteriaceae.
AB - In this study, we examined the prevalence of and mechanisms of decreased susceptibility to either imipenem or meropenem in Klebsiella pneumoniae isolates. A total of 230 clinical isolates of K. pneumoniae were collected from 13 clinical laboratories from a nationwide distribution. The MICs of imipenem and meropenem were determined by the agar dilution method. To characterize the isolates with decreased susceptibility to carbapenems (MICs of >2 μg/mL), we performed polymerase chain reaction amplification of a variety of β-lactamase genes, isoelectric focusing, and outer membrane profile analysis using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry. Three isolates (BD6, BD8, and KN16) exhibited decreased susceptibility to carbapenems with imipenem MICs of 1, 4, and 8 μg/mL and meropenem MICs of 4, 8, and 4, respectively. Isolate BD6 produced bla TEM-1 , bla SHV-12 , and bla OXA-17 ; isolate BD8 produced bla GES-3 , bla SHV-12 , and bla OXA-17 ; and isolate KN16 produced bla TEM-11 , bla SHV-12 , and bla DHA-1 . In all the 3 isolates, OmpK35 porin was not expressed, and in 1 isolate (KN16), OmpK36 was not expressed either. The prevalence of decreased susceptibility to carbapenems was low (1.3%), and none of them showed overt resistance to carbapenems. Decreased susceptibility to carbapenems can occur in K. pneumoniae when bla GES-3 , bla TEM-11 , bla SHV-12 , bla OXA-17 , and/or bla DHA-1 are produced in combination with porin loss. In addition, to our knowledge, this is the 1st report of bla OXA-17 in Enterobacteriaceae.
UR - http://www.scopus.com/inward/record.url?scp=33845429430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845429430&partnerID=8YFLogxK
U2 - 10.1016/j.diagmicrobio.2006.05.008
DO - 10.1016/j.diagmicrobio.2006.05.008
M3 - Article
VL - 57
SP - 85
EP - 91
JO - Diagnostic Microbiology and Infectious Disease
JF - Diagnostic Microbiology and Infectious Disease
SN - 0732-8893
IS - 1
ER -